Merck & Co. (MRK) stock forecast for 2025. Forecast tables and graphs.

Merck & Co. (MRK) stock forecast for 2025

The forecast has been updated: September 21, 2021 6:26


Merck & Co. stock price online today

Analyst Target Price

93.21

Dividend Date

07.10.2021

Ex Dividend Date

14.09.2021

Last Split Factor

1048:1000

Last Split Date

03.06.2021

Should you buy or sell Merck & Co. stock stock today? What is the projected target price level for 2025? How much will it cost in 2025? Merck & Co. stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2025.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $93.21 target price for Merck & Co. stock stock.

Today 200 Day Moving Average is the support level (74.95 $).

50 Day Moving Average is the support level (75.85 $).




MRK Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 71.73 70.90 73.23 3.17 %
Feb 71.30 69.39 72.70 4.55 %
Mar 69.93 67.72 71.64 5.47 %
Apr 69.15 67.91 70.65 3.88 %
May 68.35 67.12 69.31 3.16 %
Jun 67.12 66.58 67.95 2.01 %
Jul 68.89 67.13 70.57 4.88 %
Aug 70.16 67.97 71.59 5.06 %
Sep 70.38 69.00 71.93 4.07 %
Oct 70.13 69.26 71.62 3.29 %
Nov 69.29 68.71 69.90 1.71 %
Dec 69.57 67.48 70.34 4.07 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Merck & Co. stock.


Merck & Co. overview

Merck & Co. Address

2000 GALLOPING HILL ROAD, KENILWORTH, NJ, US

Market Capitalization

181 018 280 000 $

EBITDA

19 906 001 000

PE Ratio

32.56

PEG Ratio

1.343

Dividend Per Share

2.52

Dividend Yield

0.0352

EPS

2.196

Quarterly Earnings Growth YOY

-0.483

Quarterly Revenue Growth YOY

0.219

Trailing PE

32.56

Forward PE

10.65

EV To Revenue

3.958

EV To EBITDA

16.54

52 Week High

79.5

52 Week Low

66.61

50 Day Moving Average

75.85

200 Day Moving Average

74.95

Shares Outstanding

2531370000

Shares Float

2519300000

Shares Short Prior Month

23173000

Short Ratio

3.32

Percent Insiders

0.072

Percent Institutions

74.87

Merck & Co. stock forecast for this year


Merck & Co. stock forecast for Jan 2025.
Estimated Average Forecasted Merck & Co. Price: 71.73. Positive monthly dynamics of the instrument is expected with 3.174% volatility is expected.

Pessimistic forecast: 70.90

Optimistic: 73.23


Merck & Co. stock forecast for Feb 2025.
Estimated Average Forecasted Merck & Co. Price: 71.30. Negative monthly dynamics of the instrument is expected with 4.551% volatility is expected.

Pessimistic forecast: 69.39

Optimistic: 72.70


Merck & Co. stock forecast for Mar 2025.
Estimated Average Forecasted Merck & Co. Price: 69.93. Negative monthly dynamics of the instrument is expected with 5.467% volatility is expected.

Pessimistic forecast: 67.72

Optimistic: 71.64


Merck & Co. stock forecast for Apr 2025.
Estimated Average Forecasted Merck & Co. Price: 69.15. Negative monthly dynamics of the instrument is expected with 3.876% volatility is expected.

Pessimistic forecast: 67.91

Optimistic: 70.65


Merck & Co. stock forecast for May 2025.
Estimated Average Forecasted Merck & Co. Price: 68.35. Negative monthly dynamics of the instrument is expected with 3.156% volatility is expected.

Pessimistic forecast: 67.12

Optimistic: 69.31


Merck & Co. stock forecast for Jun 2025.
Estimated Average Forecasted Merck & Co. Price: 67.12. Negative monthly dynamics of the instrument is expected with 2.015% volatility is expected.

Pessimistic forecast: 66.58

Optimistic: 67.95


Merck & Co. stock forecast for Jul 2025.
Estimated Average Forecasted Merck & Co. Price: 68.89. Positive monthly dynamics of the instrument is expected with 4.881% volatility is expected.

Pessimistic forecast: 67.13

Optimistic: 70.57


Merck & Co. stock forecast for Aug 2025.
Estimated Average Forecasted Merck & Co. Price: 70.16. Positive monthly dynamics of the instrument is expected with 5.057% volatility is expected.

Pessimistic forecast: 67.97

Optimistic: 71.59


Merck & Co. stock forecast for Sep 2025.
Estimated Average Forecasted Merck & Co. Price: 70.38. Positive monthly dynamics of the instrument is expected with 4.070% volatility is expected.

Pessimistic forecast: 69.00

Optimistic: 71.93


Merck & Co. stock forecast for Oct 2025.
Estimated Average Forecasted Merck & Co. Price: 70.13. Negative monthly dynamics of the instrument is expected with 3.290% volatility is expected.

Pessimistic forecast: 69.26

Optimistic: 71.62


Merck & Co. stock forecast for Nov 2025.
Estimated Average Forecasted Merck & Co. Price: 69.29. Negative monthly dynamics of the instrument is expected with 1.705% volatility is expected.

Pessimistic forecast: 68.71

Optimistic: 69.90


Merck & Co. stock forecast for Dec 2025.
Estimated Average Forecasted Merck & Co. Price: 69.57. Positive monthly dynamics of the instrument is expected with 4.074% volatility is expected.

Pessimistic forecast: 67.48

Optimistic: 70.34



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 124.37 (24.09.2021) -0.74 %
AbbVie Inc.
ABBV 107.07 (24.09.2021) -0.27 %
Aeterna Zentaris Inc.
AEZS 0.602564 (24.09.2021) -3.68 %
Allakos Inc.
ALLK 108.17 (24.09.2021) -2.05 %
Allogene Therapeutics, Inc.
ALLO 25.66 (24.09.2021) -7.16 %
Amgen Inc.
AMGN 213.61 (24.09.2021) -0.67 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 17 (24.09.2021) -1.73 %
Aurora Cannabis Inc.
ACB 5.95 (24.09.2021) -3.25 %
Becton Dickinson and Company
BDX 253.18 (24.09.2021) -0.25 %
Biogen Inc.
BIIB 291.71 (24.09.2021) -0.51 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 133.38 (24.09.2021) -1.60 %
BioNTech SE
BNTX 333.48 (24.09.2021) -5.53 %
bluebird bio, Inc.
BLUE 18.44 (24.09.2021) -1.18 %
Boston Scientific Corp.
BSX 44.7 (24.09.2021) -0.67 %
Bristol-Myers Squibb Company
BMY 60.23 (24.09.2021) -0.66 %
Canopy Growth Corp.
CGC 13.91 (24.09.2021) -4.46 %
Castle Biosciences, Inc.
CSTL 72.44 (24.09.2021) -3.35 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.73 (24.09.2021) -2.15 %
Eli Lilly and Company
LLY 231.68 (24.09.2021) -0.22 %
Emergent BioSolutions Inc.
EBS 52.39 (24.09.2021) -2.69 %
Exelixis, Inc.
EXEL 20.35 (24.09.2021) -0.73 %
G1 Therapeutics, Inc.
GTHX 15.1 (24.09.2021) -1.44 %
Gilead Sciences, Inc.
GILD 71.19 (24.09.2021) -0.70 %
GlaxoSmithKline plc
GSK 38.39 (24.09.2021) -2.41 %
GoodRx Holdings, Inc.
GDRX 44.13 (24.09.2021) -4.75 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 69 (24.09.2021) -1.12 %
Inovio Pharmaceuticals, Inc.
INO 7.76 (24.09.2021) -3.36 %
Johnson & Johnson
JNJ 164.36 (24.09.2021) -0.30 %
Medtronic plc.
MDT 130.02 (24.09.2021) -0.47 %
Merck & Co., Inc.
MRK 73.61 (24.09.2021) 0.77 %
Moderna, Inc.
MRNA 430.14 (24.09.2021) -5.38 %
Novartis AG
NVS 82.93 (24.09.2021) -0.77 %
Novavax, Inc.
NVAX 248.16 (24.09.2021) -3.55 %
ObsEva SA
OBSV 3.15 (24.09.2021) -0.32 %
OrganiGram Holdings Inc.
OGI 2.42 (24.09.2021) -3.20 %
Pfizer Inc.
PFE 43.94 (24.09.2021) -0.57 %
Regeneron Pharmaceuticals, Inc.
REGN 638.9 (24.09.2021) -1.18 %
Sanofi
SNY 47.94 (24.09.2021) -1.60 %
Schrodinger, Inc.
SDGR 57.95 (24.09.2021) -4.23 %
Senseonics Holdings, Inc.
SENS 3.57 (24.09.2021) -4.29 %
Sorrento Therapeutics, Inc.
SRNE 7.83 (24.09.2021) -3.09 %
Stryker Corp.
SYK 276.64 (24.09.2021) 0.17 %
Sundial Growers Inc.
SNDL 0.673 (24.09.2021) -4.06 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.95 (24.09.2021) -1.10 %
Thermo Fisher Scientific Inc.
TMO 609.78 (24.09.2021) 0.25 %
Tilray, Inc.
TLRY 11.67 (24.09.2021) -2.91 %
UnitedHealth Group, Inc.
UNH 407.08 (24.09.2021) -0.23 %
Veeva Systems Inc.
VEEV 299.93 (24.09.2021) 0.41 %
Zomedica Corp.
ZOM 0.5178 (24.09.2021) -2.30 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.46 (24.09.2021) -1.55 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.